重新审视初次全髋关节置换术前INR出血风险与死亡率阈值:NSQIP 17,567例分析
该回顾性研究基于ACS NSQIP 2005–2016年17,567例初次全髋关节置换患者,按术前INR分为<1.0、1.0–<1.25、1.25–<1.5、≥1.5四组。调整混杂后,INR 1.25–<1.5组和≥1.5组出血风险均较INR<1.0组升高(OR均为1.55);仅INR≥1.5组死亡率升高(OR 2.69)。
要点
- 术前INR≥1.25与全髋置换术后出血风险升高独立相关。
- 仅INR≥1.5与术后死亡率升高独立相关(OR 2.69)。
- 随INR升高,住院时间从3.6天延长至6.3天。
核心结论
- 术前INR升高与初次全髋关节置换术后出血和死亡率升高存在显著独立关联。
- 出血风险在INR≥1.25时即显现,INR≥1.5患者死亡风险显著增加。
研究设计与样本
- 回顾性分析ACS NSQIP 2005–2016年17,567例成人初次全髋关节置换患者。
- 按术前INR分为<1.0、1.0–<1.25、1.25–<1.5、≥1.5四组,多变量logistic回归控制基线差异。
主要发现
- INR<1.0组占20.5%,1.0–<1.25组占73.6%,1.25–<1.5组占4.2%,≥1.5组占1.8%。
- 死亡率从INR<1.0组的0.3%升至INR≥1.5组的4.9%(p<0.001)。
- 出血风险从INR<1.0组的13.2%升至INR≥1.5组的29.3%(p<0.001)。
- 调整后,INR 1.25–<1.5组出血OR 1.55(95%CI 1.26–1.92),INR≥1.5组出血OR 1.55(95%CI 1.15–2.08),均以INR<1.0组为参照。
- 仅INR≥1.5组死亡率升高(OR 2.69,95%CI 1.07–6.76);住院时间从3.6天延长至6.3天(p<0.001)。
关键数值与推荐
- 出血风险升高的INR阈值为≥1.25(OR 1.55,95%CI 1.26–1.92 for 1.25–<1.5;OR 1.55,95%CI 1.15–2.08 for ≥1.5)。
- 死亡率升高的INR阈值为≥1.5(OR 2.69,95%CI 1.07–6.76)。
临床怎么用
- 术前INR≥1.25的初次全髋关节置换患者出血风险升高,INR≥1.5者死亡风险升高。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Efforts to identify preoperative risk factors for primary total hip arthroplasty have amplified with its increasing incidence. The international normalized ratio (INR) is 1 measure that may influence postoperative outcomes. This study of a national database assessed whether there exists an association between preoperative INR and postoperative bleeding and mortality among patients who underwent primary total hip arthroplasty. METHODS: We retrospectively analyzed 17,567 adult patients who underwent primary total hip arthroplasty in the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) between 2005 and 2016. Patients were stratified by preoperative INR into 4 groups: INR <1.0, 1.0 to <1.25, 1.25 to <1.5, and ≥1.5. Bleeding necessitating transfusion was the primary outcome, and secondary outcomes included mortality, infection, and readmission. Multivariable logistic regressions controlled for baseline differences. RESULTS: Among the patients who underwent total hip arthroplasty, 20.5% had INR <1.0, 73.6% had INR 1.0 to <1.25, 4.2% had INR 1.25 to <1.5, and 1.8% had INR ≥1.5. Mortality increased incrementally from 0.3% for INR <1.0 to 4.9% for INR ≥1.5 (p < 0.001), and bleeding risk increased from 13.2% for INR <1.0 to 29.3% for INR ≥1.5 (p < 0.001). After adjustment, bleeding risk was increased for INR 1.25 to <1.5 (odds ratio [OR], 1.55 [95% confidence interval (CI), 1.26 to 1.92]) and INR ≥1.5 (OR, 1.55 [95% CI, 1.15 to 2.08]) compared with INR <1.0. The only group associated with increased mortality was INR ≥1.5 (OR, 2.69 [95% CI, 1.07 to 6.76]). The length of stay significantly increased with increasing INR, from 3.6 to 6.3 days (p < 0.001). CONCLUSIONS: This study found a significant, independent effect between increased preoperative INR and increased bleeding and mortality. Bleeding risk becomes evident at INR ≥1.25, and those patients with INR ≥1.5 are at significantly increased risk of mortality. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Rudasill SE, Liu J, Kamath AF, et al. Revisiting the International Normalized Ratio Threshold for Bleeding Risk and Mortality in Primary Total Hip Arthroplasty: A National Surgical Quality Improvement Program Analysis of 17,567 Patients. J Bone Joint Surg Am. 2020. PMID: 31609891. doi:10.2106/JBJS.19.00160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。